reviewEuropean Journal of Medicinal ChemistryMar 14, 2022GREEN OA

Toll-like receptor 4 (TLR4) inhibitors: Current research and prospective

YZYong-Sheng ZhangXLXinjie LiangXBXuefei BaoWXWei XiaoGCGuoliang Chen

Shenyang Pharmaceutical University · Kanion Pharmaceutical (China)

PubMed
Indexed incrossrefdatacitepubmed

Abstract

No abstract available for this paper.

Citation impact

286
total citations
FWCI
21.89
Percentile
100%
References
129
Citations per year

Authors

5

Topics & keywords

Topics
Keywords
  • TLR4
  • Toll-like receptor
  • Chemistry
  • Receptor
  • Docking (animal)
  • Lipopolysaccharide
  • Pharmacology
  • Innate immune system
UN Sustainable Development Goals
  • Good health and well-being
No related works found for this paper.

Funding